Connection

David Gutman to Anti-Anxiety Agents

Back to Details
This is a "connection" page, showing publications David Gutman has written about Anti-Anxiety Agents.
David Gutman
Connection Strength
0.459
Anti-Anxiety Agents
  1. Persistent anxiolytic affects after chronic administration of the CRF1 receptor antagonist R121919 in rats. Neuropharmacology. 2011 Jun; 60(7-8):1135-41.
    View in: PubMed
    Score: 0.343
  2. The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal. Psychopharmacology (Berl). 2007 Jun; 192(3):385-96.
    View in: PubMed
    Score: 0.066
  3. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J Pharmacol Exp Ther. 2003 Feb; 304(2):874-80.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.